Related Experiment Video
Updated: Jun 11, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial
Jing Cheng1, Carl Gao2, Reeta Ala-Jaakkola1
1Department of Health, International Flavors & Fragrances, Kantvik, Finland.
This study found that Bifidobacterium animalis subsp lactis HN019 did not significantly improve complete spontaneous bowel movements (CSBMs) in adults with functional constipation compared to a placebo. Further research is needed to explore probiotic efficacy for constipation relief.
Area of Science:
- Gastroenterology
- Microbiology
- Clinical Nutrition
Background:
- Probiotic supplementation is often suggested to improve bowel movements.
- However, robust clinical evidence from large-scale, well-designed studies is limited.
- Functional constipation affects a significant portion of the population, necessitating effective interventions.
Purpose of the Study:
- To assess the efficacy of Bifidobacterium animalis subsp lactis HN019 in improving complete spontaneous bowel movements (CSBMs) in individuals with functional constipation.
- To evaluate the impact of this probiotic on various secondary outcomes related to bowel function and gut health.
- To provide high-quality evidence regarding probiotic use for constipation management.
Main Methods:
- A randomized, triple-blind, placebo-controlled trial involving 229 participants with functional constipation.
- Participants received either Bifidobacterium animalis subsp lactis HN019 or a maltodextrin placebo daily for 8 weeks.
- Primary outcome was the change in weekly CSBMs; secondary outcomes included stool consistency, abdominal pain, bloating, and fecal analyses.
Main Results:
- No significant difference was observed in the change of weekly CSBMs from baseline between the HN019 group and the placebo group.
- Secondary outcomes such as stool consistency, straining, abdominal pain, and bloating also showed no significant improvements with probiotic intervention.
- Fecal analyses did not reveal significant alterations in microbiota composition or other measured parameters between groups.
Conclusions:
- Daily consumption of Bifidobacterium animalis subsp lactis HN019 at a dose of 4.69 × 10^9 CFU did not demonstrate superior efficacy over placebo in increasing CSBMs.
- This large, well-conducted clinical trial does not support the use of this specific probiotic for improving bowel movements in functional constipation.
- The findings highlight the need for continued rigorous research into the role of probiotics in managing constipation.
More Related Videos
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.